Interim findings from single-dose human trial support further clinical evaluation of MDX-010 Nov. 6, 2001
OvaRex associated with improvement in clinical outcome and good safety in advanced ovarian cancer Nov. 2, 2001
AACR-NCI-EORTC news: little severe toxicity seen in dose-escalating trial of IL-2 mutein Oct. 31, 2001
RSS